Treating liver disease in people living with HIV
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
Learn MoreThe CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
Learn MoreDr. Elizabeth King is an infectious disease specialist who joined the CTN as a Postdoctoral Fellow in July 2020 to investigate the evolution of menopausal symptoms in women living with HIV
Learn MoreThe WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Learn MoreDiscover more about a selection of the 2020/21 Postdoctoral Fellow presentations, which will be taking place at the virtual CTN Fall Meetings on October 21, 2020
Learn MoreSince 1993, the CTN Community Advisory Committee (CAC) has changed the course of HIV research in Canada. Let’s meet four new members who joined the CAC in 2020
Learn MoreThe Black PRAISE team have pioneered a novel intervention aimed at reducing HIV-related stigma while strengthening the HIV knowledge base among Black church congregations in Ontario
Learn MoreNew funding for CTN 300-2 will allow the study team to document COVID-19 infection, immunity, and related determinants in gay, bisexual, and other men who have sex with men
Learn MoreDr. Bertrand Lebouché joins the creators of the health app Opal to repurpose it for COVID-19 patients recovering from home
Learn MoreLearn about Dr. McClymont's passion for HIV research and the project she plans to undertake during her CTN fellowship
Learn MoreThe 15th International Workshop on HIV Transmission will take place on 10 and 11 December 2020 as a virtual meeting
Learn MoreThe CTN 262 CHIWOS study have launched an all-encompassing Women-Centred HIV Care model and two toolkits
Learn More